Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)
Others
Ratios

Clene (CLNN) EBIT (2020 - 2025)

Clene (CLNN) has 6 years of EBIT data on record, last reported at -$5.7 million in Q3 2025.

  • For Q3 2025, EBIT rose 27.44% year-over-year to -$5.7 million; the TTM value through Sep 2025 reached $530000.0, up 101.54%, while the annual FY2024 figure was -$8.3 million, 79.58% up from the prior year.
  • EBIT reached -$5.7 million in Q3 2025 per CLNN's latest filing, up from -$5.8 million in the prior quarter.
  • Across five years, EBIT topped out at $33.8 million in Q4 2021 and bottomed at -$13.8 million in Q2 2021.
  • Average EBIT over 5 years is -$3.8 million, with a median of -$9.5 million recorded in 2023.
  • The widest YoY moves for EBIT: up 666.86% in 2021, down 202.02% in 2021.
  • A 5-year view of EBIT shows it stood at $33.8 million in 2021, then dropped by 9.95% to $30.4 million in 2022, then plummeted by 132.63% to -$9.9 million in 2023, then skyrocketed by 262.5% to $16.1 million in 2024, then tumbled by 135.09% to -$5.7 million in 2025.
  • Per Business Quant database, its latest 3 readings for EBIT were -$5.7 million in Q3 2025, -$5.8 million in Q2 2025, and -$4.1 million in Q1 2025.